Susquehanna International Group
UBIO

Susquehanna International Group’s Proshares UltraPro NASDAQ Biotechnology UBIO Stock Holding History

Susquehanna International Group’s Portfolio UBIO Stock Details UBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-9,400
Closed -$271K – 10426
2016
Q3 		$271K Sell
9,400
-3,400
-27% -$96.8K ﹤0.01% 7099
2016
Q2 		$271K Buy
+12,800
New +$324K ﹤0.01% 7119

Other funds holding UBIO

Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Susquehanna International Group's UBIO Position: Q1 2020 in Review

Susquehanna International Group sold out of Proshares UltraPro NASDAQ Biotechnology (UBIO) in Q1 2020, closing a stake of 33,955 shares — an estimated $1.11M sold.

Susquehanna International Group first reported a position in UBIO in Q4 2015 and held it in 12 quarters. The position peaked at $1.3M in Q4 2015. 1 fund tracked by Wall St. Rank holds UBIO as of Q1 2020.

  • Susquehanna International Group reported no remaining Proshares UltraPro NASDAQ Biotechnology position as of Q1 2020 after selling out during the quarter.
  • Susquehanna International Group sold 33,955 Proshares UltraPro NASDAQ Biotechnology shares in Q1 2020, an estimated $1.11M.
  • Susquehanna International Group first reported a position in Proshares UltraPro NASDAQ Biotechnology in Q4 2015 and held it in 12 quarters.
  • Susquehanna International Group's Proshares UltraPro NASDAQ Biotechnology position peaked at $1.3M in Q4 2015.
  • 1 fund tracked by Wall St. Rank held Proshares UltraPro NASDAQ Biotechnology as of Q1 2020.

Based on Susquehanna International Group's 13F filing for Q1 2020, filed 15 May 2020.